Harlan F. Weisman - Aug 15, 2023 Form 4 Insider Report for TFF Pharmaceuticals, Inc. (TFFP)

Role
President and CEO, Director
Signature
/s/ Harlan F. Weisman, by Kirk Allen Coleman, as Attorney-in-Fact
Stock symbol
TFFP
Transactions as of
Aug 15, 2023
Transactions value $
$150,000
Form type
4
Date filed
8/15/2023, 08:00 AM
Previous filing
Mar 13, 2023
Next filing
Apr 22, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TFFP Common Stock Purchase $150K +600K +279.57% $0.25 815K Aug 15, 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Acquired from the Issuer pursuant to the public offering described in the Issuer's Prospectus filed with the U.S. Securities and Exchange Commission on August 14, 2023.